• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD23、p45(BLAST-2、EBVCS)抗原的结扎触发活化B淋巴细胞的细胞周期进程。

Ligation of the CD23,p45 (BLAST-2,EBVCS) antigen triggers the cell-cycle progression of activated B lymphocytes.

作者信息

Gordon J, Rowe M, Walker L, Guy G

出版信息

Eur J Immunol. 1986 Sep;16(9):1075-80. doi: 10.1002/eji.1830160908.

DOI:10.1002/eji.1830160908
PMID:2428624
Abstract

CD23,p45 (BLAST-2,EBVCS) is a 45-kDa lineage-restricted antigen which appears on the surface of human B cells shortly after activation. A monoclonal antibody (MHM6) to CD23,p45, as well as a polyclonal rabbit antibody raised against the purified antigen were found to promote DNA synthesis in purified tonsillar B cells which had been activated with phorbol ester. Interleukin 1, which was not, by itself, stimulatory for either resting or activated B cells, significantly augmented the growth-promoting properties of MHM6. Kinetic studies indicated that while MHM6 exerted its influence in early G1, interleukin 1 acted later in the cycle just prior to the entry of cells into S phase. The findings demonstrate a role for CD23,p45 in triggering the progression of activated B lymphocytes through the G1 phase of the cell cycle. The possibility that this antigen serves as a receptor for a B cell stimulatory factor is discussed.

摘要

CD23,p45(BLAST-2,EBVCS)是一种45 kDa的谱系限制性抗原,在人B细胞激活后不久出现在其表面。已发现一种针对CD23,p45的单克隆抗体(MHM6)以及一种针对纯化抗原产生的兔多克隆抗体可促进用佛波酯激活的纯化扁桃体B细胞中的DNA合成。白细胞介素1本身对静止或激活的B细胞均无刺激作用,但能显著增强MHM6的促生长特性。动力学研究表明,MHM6在G1早期发挥作用,而白细胞介素1在细胞进入S期之前的细胞周期后期起作用。这些发现证明了CD23,p45在触发活化B淋巴细胞通过细胞周期G1期进程中的作用。本文讨论了该抗原作为B细胞刺激因子受体的可能性。

相似文献

1
Ligation of the CD23,p45 (BLAST-2,EBVCS) antigen triggers the cell-cycle progression of activated B lymphocytes.CD23、p45(BLAST-2、EBVCS)抗原的结扎触发活化B淋巴细胞的细胞周期进程。
Eur J Immunol. 1986 Sep;16(9):1075-80. doi: 10.1002/eji.1830160908.
2
Evidence for an association between CD23 and the receptor for a low molecular weight B cell growth factor.CD23与低分子量B细胞生长因子受体之间关联的证据。
Eur J Immunol. 1986 Dec;16(12):1627-30. doi: 10.1002/eji.1830161225.
3
Differential expression of cell activation markers after stimulation of resting human B lymphocytes.静息人B淋巴细胞受到刺激后细胞活化标志物的差异表达。
J Immunol. 1984 Jun;132(6):2857-61.
4
The roles of T cell factors in activation, cell cycle progression, and differentiation of human B cells.T细胞因子在人类B细胞激活、细胞周期进程及分化中的作用。
J Immunol. 1985 Mar;134(3):1690-701.
5
Triggering of B lymphocytes through CD23: epitope mapping and studies using antibody derivatives indicate an allosteric mechanism of signalling.通过CD23触发B淋巴细胞:表位作图及使用抗体衍生物的研究表明一种变构信号传导机制。
Immunology. 1987 Apr;60(4):517-21.
6
Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.经佛波酯和单克隆抗μ抗体激活后,人B细胞对B细胞生长因子的反应性。
J Immunol. 1985 Apr;134(4):2470-6.
7
Cognate interactions between helper T cells and B cells. III. Contact-dependent, lymphokine-independent induction of B cell cycle entry by activated helper T cells.辅助性T细胞与B细胞之间的同源相互作用。III. 活化的辅助性T细胞对B细胞周期进入的接触依赖性、不依赖淋巴因子的诱导。
J Immunol. 1989 Sep 15;143(6):1807-14.
8
Functional interaction between B cell subpopulations defined by CD23 expression.由CD23表达定义的B细胞亚群之间的功能相互作用。
Eur J Immunol. 1988 Nov;18(11):1753-60. doi: 10.1002/eji.1830181115.
9
A role for Lyb-2 in B cell activation mediated by a B cell stimulatory factor.Lyb-2在由B细胞刺激因子介导的B细胞活化中的作用。
J Immunol. 1986 Sep 1;137(5):1475-81.
10
Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I.人B细胞活化与细胞周期进程:用抗μ抗体和金黄色葡萄球菌考恩I株进行刺激。
Eur J Immunol. 1984 Feb;14(2):115-21. doi: 10.1002/eji.1830140203.

引用本文的文献

1
On the complexity of IgE: The role of structural flexibility and glycosylation for binding its receptors.论免疫球蛋白E的复杂性:结构灵活性和糖基化在其与受体结合中的作用
Front Allergy. 2023 Mar 28;4:1117611. doi: 10.3389/falgy.2023.1117611. eCollection 2023.
2
Reviving lost binding sites: Exploring calcium-binding site transitions between human and murine CD23.恢复丢失的结合位点:探索人源和鼠源 CD23 之间的钙结合位点转变。
FEBS Open Bio. 2021 Jul;11(7):1827-1840. doi: 10.1002/2211-5463.13214. Epub 2021 Jun 24.
3
Impact of Plasma Membrane Domains on IgG Fc Receptor Function.
细胞膜域对 IgG Fc 受体功能的影响。
Front Immunol. 2020 Jun 30;11:1320. doi: 10.3389/fimmu.2020.01320. eCollection 2020.
4
CD23/FcεRII: molecular multi-tasking.CD23/FcεRII:分子的多任务处理。
Clin Exp Immunol. 2010 Oct;162(1):12-23. doi: 10.1111/j.1365-2249.2010.04210.x.
5
Surface expression and release of soluble forms of CD8 and CD23 in CD40- and IL-4-activated mononuclear cells from patients with Graves' disease (GD).格雷夫斯病(GD)患者经CD40和IL-4激活的单核细胞中CD8和CD23可溶性形式的表面表达及释放
Clin Exp Immunol. 1998 Aug;113(2):309-14. doi: 10.1046/j.1365-2249.1998.00658.x.
6
Variant sublines of the human B-lymphoma cells Namalwa are at different stages of differentiation.人B淋巴瘤细胞Namalwa的变异亚系处于不同的分化阶段。
Immunology. 1987 Jul;61(3):383-6.
7
The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed CD23 (sCD23).狨猴B淋巴细胞系(B95-8)产生并对B细胞生长和分化因子作出反应:可溶性CD23(sCD23)的作用。
Immunology. 1988 Nov;65(3):379-84.
8
The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells.活化抗原BLAST-2脱落后,是正常和转化B细胞的一种自分泌促B细胞生长因子。
EMBO J. 1987 Jun;6(6):1637-42. doi: 10.1002/j.1460-2075.1987.tb02412.x.
9
Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.爱泼斯坦-巴尔病毒核抗原2特异性诱导B细胞活化抗原CD23的表达。
Proc Natl Acad Sci U S A. 1987 May;84(10):3452-6. doi: 10.1073/pnas.84.10.3452.
10
Autocrine growth of human B lymphocytes: maintained response to autostimulatory factors is the special feature of immortalization by Epstein-Barr virus--a hypothesis.人B淋巴细胞的自分泌生长:对自身刺激因子的持续反应是爱泼斯坦-巴尔病毒永生化的特殊特征——一种假说。
Med Oncol Tumor Pharmacother. 1986;3(3-4):269-73. doi: 10.1007/BF02935004.